Julie Papanek Grant, Director at Day One Biopharmaceuticals, Inc. (DAWN), sold 488,691 shares at $23.68 ($11.6M) on 2022-09-14, disclosed to the SEC on 2022-09-15.
Open-market sale of $11.6M DAWN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.39 | 86,644 | $2.1M | 18.2% |
| 2 | $24.39 | 86,644 | $2.1M | 18.2% |
| 3 | $25.01 | 1,003 | $25K | 0.2% |
| 4 | $23.68 | 105,727 | $2.5M | 21.6% |
| 5 | $23.68 | 105,727 | $2.5M | 21.6% |
| 6 | $24.29 | 384 |
| $9K |
| 0.1% |
| 7 | $22.79 | 47,967 | $1.1M | 9.4% |
| 8 | $22.79 | 47,967 | $1.1M | 9.4% |
| 9 | $23.73 | 3,314 | $79K | 0.7% |
| 10 | $23.73 | 3,314 | $79K | 0.7% |
| Total | $23.76 avg | 488,691 | $11.6M | 100% |
| Filing → |
| DAWN | SELL | 2023-01-04 | $1.0M | — | Filing → |
| DAWN | SELL | 2022-12-12 | $192K | — | Filing → |
| DAWN | SELL | 2022-12-05 | $320K | — | Filing → |